TSE:BLU

BELLUS Health (BLU) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
C$19.48
C$19.48
52-Week Range
N/A
Volume
28,666 shs
Average Volume
59,471 shs
Market Capitalization
C$2.47 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BLU stock logo

About BELLUS Health Stock (TSE:BLU)

BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.

BLU Stock News Headlines

Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!
The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...
Mind Medicine Inc Ordinary Shares MNMD
Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!
The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...
Closing Bell: Bellus Health Inc down on Thursday (BLU)
Closing Bell: Bellus Health Inc down on Monday (BLU)
Closing Bell: Bellus Health Inc up on Friday (BLU)
GSK pays £1.6bn for Canada's Bellus Health
Closing Bell: Bellus Health Inc down on Wednesday (BLU)
See More Headlines
Receive BLU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BELLUS Health and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
74
Year Founded
N/A

Profitability

Net Income
C$-86,790,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$16,000.00
Book Value
C$2.91 per share

Miscellaneous

Free Float
N/A
Market Cap
C$2.47 billion
Optionable
Not Optionable
Beta
-0.28
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Roberto Francesco Bellini (Age 43)
    Pres, CEO & Director
    Comp: $790.35k
  • Mr. Ramzi Benamar (Age 50)
    Chief Financial Officer
    Comp: $650.48k
  • Dr. Andreas Orfanos FFPM (Age 64)
    M.B.B.Ch, MBA, Chief Operating Officer
    Comp: $417.58k
  • Dr. Denis Garceau Ph.D. (Age 66)
    Chief Scientific Officer
    Comp: $496.56k
  • Dr. Catherine M. Bonuccelli M.D. (Age 65)
    Chief Medical Officer
    Comp: $741.66k
  • Mr. Daniel Matthews
    Director of Investor Relations & Communications
  • Mr. Tony Matzouranis (Age 50)
    Chief Bus. Officer
  • Mr. Sebastien Roy (Age 47)
    Corp. Sec.

BLU Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of BELLUS Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BELLUS Health investors own include Exxon Mobil (XOM), Bombardier (BDRBF), AbbVie (ABBV), Energy Transfer (ET), General Electric (GE), Coca-Cola (KO), Alexion Pharmaceuticals (ALXN), Advanced Micro Devices (AMD), Boeing (BA) and Walt Disney (DIS).

How do I buy shares of BELLUS Health?

Shares of BLU stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:BLU) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners